2015-08-11T11:14:42-05:00 2014-09-30 410746749 CLIFTONLARSONALLEN LLP 4250 N FAIRFAX DRIVE SUITE 1020 ARLINGTON VA 22203 990 2013-10-01 522059102 NATIONAL BLOOD FOUNDATION RESEARCH AND EDUCATION TRUST FUND NATI 3019076977 8101 GLENBROOK ROAD BETHESDA MD 20814 THOMAS HOPKINS CHIEF FINANCIAL OFFICER 3019076977 2015-08-10 1 MELISSA LAFFERTY P01222987 5712279500 2013 2016-02-25 16:41:14Z MIRIAM MARKOWITZ 8101 GLENBROOK ROAD BETHESDA MD 20814 1900594 0 X WWW.AABB.ORG X 1997 MD TO ADVANCE, THROUGH SCIENTIFIC RESEARCH, THE PRACTICE AND STANDARDS OF TRANSFUSION MEDICINE AND CELLULAR AND RELATED BIOLOGICAL THERAPIES. 8 8 0 25 0 0 776482 830599 0 0 1467800 1062732 1029 7263 2245311 1900594 300000 516587 0 0 0 0 0 0 74754 227943 173752 527943 690339 1717368 1210255 10605810 11317084 15621 18367 10590189 11298717 TO ADVANCE, THROUGH SCIENTIFIC RESEARCH, THE PRACTICE AND STANDARDS OF TRANSFUSION MEDICINE AND CELLULAR AND RELATED BIOLOGICAL THERAPIES. 0 0 575126 516587 SEVEN (7) GRANTS WERE AWARDED TO SEVEN (7) PRINCIPAL INVESTIGATORS AT SEVEN (7) INSTITUTIONS. SIX (6) WERE AWARDED FOR BLOOD TRANSFUSION RESEARCH AND ONE (1) WAS AWARDED FOR CELLULAR THERAPY RESEARCH. THE RESEARCH FINDINGS ARE PUBLISHED BY AMERICAN ASSOCIATION OF BLOOD BANKS AND OTHER BLOOD TRANSFUSION AND SCIENTIFIC JOURNALS AND PERIODICALS. 575126 1 1 0 0 0 0 0 0 0 1 0 0 0 0 0 1 1 0 0 0 1 0 1 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 X 8 8 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 X THOMAS HOPKINS 2403336615 8101 GLENBROOK RD BETHESDA MD 20814 JACK MCGUIRE MBA TRUSTEE 1.00 X 0 0 0 JEANNE HENDRICKSON MD TRUSTEE 1.00 X 0 0 0 TOM GRAHAM MBA TRUSTEE 1.00 X 0 0 0 LOUIS M KATZ MD TRUSTEE 1.00 X 0 0 0 DAVID PEREZ CHAIR 1.00 X X 0 0 0 THOMAS PUCKETT TRUSTEE 1.00 2.00 X 0 0 0 J DANIEL CONNOR MBA TRUSTEE 1.00 X X 0 0 0 ZBIGNIEW SZCZEPIORKOWSKI MD TRUSTEE 1.00 2.00 X X 0 0 0 KAREN L SHOOS JD FORMER CEO 2.00 40.00 X 0 302565 38918 MARK R CONHEADY FORMER CFO 2.00 40.00 X 0 184704 27724 MIRIAM MARKOWITZ CEO, EX-OFFICIO MEMBER 2.00 40.00 X 0 226946 49243 THOMAS HOPKINS CFO 2.00 40.00 X 0 0 0 0 714215 115885 0 0 1 0 0 830599 830599 1062732 1062732 OTHER INCOME 900099 7263 7263 7263 1900594 0 0 1069995 450000 450000 66587 66587 124590 37377 12459 74754 23590 23590 1527 1527 5545 2662 2883 AWARD FEES 18500 18500 690339 575126 40459 74754 273405 250202 9988851 10817811 343554 249071 10605810 11317084 15621 18367 15621 18367 X 9373077 10056680 517112 542037 700000 700000 10590189 11298717 10605810 11317084 1210255 -501727 0 X 0 1 X 1 0 X X X 0 0 0 AMERICAN ASSOCIATION OF BLOOD BANKS 362384118 7 1 1 1 0 1 0 RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 886598 25 45618 11000 15648 905593 800765 1395 98012 13574 886598 633023 101664 91083 25005 800765 689125 -19605 36497 633023 656633 3990 53204 24702 689125 0.77300 0.22700 0 0 0 X 1899067 0 1899067 1527 1527 1900594 688812 0 688812 1527 1527 690339 PART V, LINE 4: PERMANENTLY RESTRICTED NET ASSETS REPRESENTS CONTRIBUTIONS RECEIVED FOR THE HEMPHILL-JORDAN LEADERSHIP AWARD, THE EMILY COOLEY MEMORIAL AWARD AND LECTURESHIP, THE TIBOR GREENWALT MEMORIAL AWARD AND LECTURESHIP, AND A CONTRIBUTION MADE BY THE ESTATE OF BERNICE HEMPHILL. THE EARNINGS FROM THE HEMPHILL-JORDAN CONTRIBUTIONS ARE TEMPORARILY RESTRICTED FOR THE PURPOSE OF HONORING LEADERS FROM THE BLOOD BANKING AND TRANSFUSION MEDICINE COMMUNITY WHO HAVE MADE SIGNIFICANT CONTRIBUTIONS IN THE AREAS OF ADMINISTRATION, QUALITY PROGRAMS, LAW, AND/OR GOVERNMENT AFFAIRS. THE EARNINGS FROM THE EMILY COOLEY CONTRIBUTION ARE TEMPORARILY RESTRICTED FOR THE PURPOSE OF HONORING AN INDIVIDUAL WHO HAS DEMONSTRATED TEACHING ABILITY AND HAS MADE A MAJOR CONTRIBUTION TO THE FIELD OF IMMUNOHEMATOLOGY AND TRANSFUSION MEDICINE OR CELLULAR THERAPIES. THE EARNINGS ON THE TIBOR GREENWALT CONTRIBUTION ARE TO BE ADDED TO THE ENDOWMENT UNTIL THE TOTAL ENDOWMENT REACHES $100,000, AT WHICH TIME ANY FUTURE EARNINGS WILL BE TEMPORARILY RESTRICTED FOR THE PURPOSE OF THE AWARD AND LECTURESHIP HONORING AN INDIVIDUAL WHO HAS MADE MAJOR SCIENTIFIC OR CLINICAL CONTRIBUTIONS TO HEMATOLOGY AND TRANSFUSION MEDICINE. THE EARNINGS FROM THE BERNICE HEMPHILL ESTATE CONTRIBUTION ARE TEMPORARILY RESTRICTED FOR THE PURPOSE OF ESTABLISHING A BLOOD-BANKING MUSEUM AT THE NATIONAL HEADQUARTERS. PART X, LINE 2: THE TRUST HAS ADOPTED THE INCOME TAX STANDARD FOR UNCERTAIN INCOME TAX POSITIONS. THE TRUST HAS EVALUATED ITS TAX POSITIONS AND DETERMINED THAT THEY ARE MORE-LIKELY-THAN-NOT TO BE SUSTAINED ON EXAMINATION. THE TRUST'S INCOME TAX RETURNS ARE SUBJECT TO REVIEW AND EXAMINATION BY FEDERAL AND STATE AUTHORITIES. THE TRUST IS NOT AWARE OF ANY ACTIVITIES THAT WOULD JEOPARDIZE ITS TAX-EXEMPT STATUS. THE TRUST IS NOT AWARE OF ANY ACTIVITIES THAT ARE SUBJECT TO TAX ON UNRELATED BUSINESS INCOME OR EXCISE OR OTHER TAXES. THE TAX RETURNS FOR THE FISCAL YEARS 2011 THROUGH 2013 ARE OPEN TO EXAMINATION BY FEDERAL AND STATE AUTHORITIES. 0 SUB-SAHARAN AFRICA 0 0 GRANTS TO RECIPIENTS 66587 0 0 0 0 0 0 66587 0 66587 GRANT FOR SCIENTIFIC RESEARCH REGARDING RISK FACTORS OF HIV INFECTION IN SUB-SAHARAN AFRICA BLOOD DONORS - A PILOT PHASE IN CAMEROON SUB-SAHARAN AFRICA 1 66600 WIRE 0 0 0 0 0 0 0 GRANT FOR SCIENTIFIC RESEARCH ON THE EFFECT OF GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY ON RED BLOOD CELL STORAGE 1 75000 GRANT FOR SCIENTIFIC RESEARCH FOR A GENOMICS APPROACH TO TRANSFUSION RESPONDERS IN SICKLE CELL DISEASE 1 75000 GRANT FOR SCIENTIFIC RESEARCH FOR ANGIOTENSIN IN STEM CELL RECRUITMENT AND MOBILIZATION 1 75000 GRANT FOR SCIENTIFIC RESEARCH ON THE ESTABLISHMENT AND MAINTENANCE OF LYMPHOCYTE TOLERANCE TO RED BLOOD CELL ANTIGENS 1 75000 GRANT FOR SCIENTIFIC RESEARCH FOR THE PHYSIOLOGIC EFFECTS OF RBC STORAGE IN CHRONIC TRANSFUSION RECIPIENTS: VASOREACTIVITY, EXERCISE CAPACITY, AND OXYGEN CONSUMPTION 1 75000 GRANT FOR SCIENTIFIC RESEARCH FOR THE RECOMBINANT GLYCOPROTEIN FRAGMENTS FOR IMPROVED DETECTION OF ALLOANTIBODIES IN NEONATAL ALLOIMMUNE THROMBOCYTOPENIA (NAIT) 1 75000 0 0 0 0 0 0 0 0 0 KAREN L SHOOS JD FORMER CEO 0 252733 0 45000 0 4832 0 18688 0 20230 0 341483 0 0 MARK R CONHEADY FORMER CFO 0 165445 0 15000 0 4259 0 15936 0 11788 0 212428 0 0 MIRIAM MARKOWITZ CEO, EX-OFFICIO MEMBER 0 225755 0 0 0 1191 0 28951 0 20292 0 276189 0 0 PART I, LINE 3 THE CEO RECEIVES NO COMPENSATION FROM NATIONAL BLOOD FOUNDATION RESEARCH AND EDUCATION TRUST (NBFRET). THE CEO RECEIVES COMPENSATION FROM NBFRET'S RELATED ORGANIZATION, AMERICAN ASSOCIATION OF BLOOD BANKS (AABB). AABB'S PROCEDURE FOR DETERMINING THE COMPENSATION OF THE CEO IS: AT LEAST EVERY TWO YEARS, A COMPENSATION AND BENEFITS SPECIALIST REVIEWS ALL JOB AND JOB DESCRIPTIONS AND ENSURES THAT THE SALARY RANGE FOR EACH JOB IS COMPETITIVE WITH MARKET CONDITIONS. AABB'S HUMAN RESOURCES COMMITTEE ANNUALLY REVIEWS THE COMPENSATION OF OFFICERS AND KEY EMPLOYEES. THE PROCESS WAS LAST UNDERTAKEN IN 2013 FOR THE CEO. FORM 990, PART VI, SECTION A, LINE 8B THE ORGANIZATION DOES NOT HAVE ANY COMMITTEES WITH AUTHORITY TO ACT ON BEHALF OF THE GOVERNING BODY. FORM 990, PART VI, SECTION B, LINE 11 THE AUDIT AND ETHICS COMMITTEE WILL MEET AND APPROVE THE 990 AND AFTER THAT WILL PRESENT THE ACTION TAKEN AS A REPORT OF THE COMMITTEE TO THE FULL BOARD AT ITS NEXT REGULARLY SCHEDULED MEETING. FORM 990, PART VI, SECTION B, LINE 12 THE ORGANIZATION HAS ADOPTED THE POLICY OF ITS RELATED ORGANIZATION, AMERICAN ASSOCIATION OF BLOOD BANKS. ALL CONFLICT OF INTEREST FORMS ARE FILLED OUT ANNUALLY. TWICE A YEAR AT THE BOARD MEETINGS, THERE IS A POLICY TO ASK THAT ANYONE WITH A PERCEIVED CONFLICT OF INTEREST ABSTAIN FROM VOTING AND IN SOME CASES, THEY ARE ASKED TO LEAVE THE ROOM. FORM 990, PART VI, SECTION B, LINE 15 PART VI, LINE 15: THE CEO, OFFICERS AND KEY EMPLOYEES RECEIVE NO COMPENSATION FROM NATIONAL BLOOD FOUNDATION RESEARCH AND EDUCATION TRUST (NBFRET). THE CEO, OFFICERS AND KEY EMPLOYEES RECEIVE COMPENSATION FROM NBFRET'S RELATED ORGANIZATION, AMERICAN ASSOCIATION OF BLOOD BANKS (AABB). AABB'S PROCEDURE FOR DETERMINING THE COMPENSATION OF THE CEO IS: AT LEAST EVERY TWO YEARS, A COMPENSATION AND BENEFITS SPECIALIST REVIEWS ALL JOB AND JOB DESCRIPTIONS AND ENSURES THAT THE SALARY RANGE FOR EACH JOB IS COMPETITIVE WITH MARKET CONDITIONS. AABB'S HUMAN RESOURCES COMMITTEE ANNUALLY REVIEWS THE COMPENSATION OF OFFICERS AND KEY EMPLOYEES. THE PROCESS WAS LAST UNDERTAKEN IN 2013 FOR THE CEO. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION'S GOVERNING DOCUMENTS AND FINANCIAL STATEMENTS ARE AVAILABLE UPON REQUEST; THE ORGANIZATION FOLLOWS THE SAME CONFLICT OF INTEREST POLICY AS ITS RELATED ORGANIZATION, AMERICAN ASSOCIATION OF BLOOD BANKS, AND THE COI POLICY IS AVAILBLE THROUGH THE AMERICAN ASSOCIATION OF BLOOD BANKS' WEBSITE (WWW.AABB.ORG). FORM 990, PART VI, SECTION B, LINE 13 THE ORGANIZATION HAS ADOPTED THE POLICY OF ITS RELATED ORGANIZATION, AMERICAN ASSOCIATION OF BLOOD BANKS. FORM 990, PART VI, SECTION B, LINE 14 THE ORGANIZATION HAS ADOPTED THE POLICY OF ITS RELATED ORGANIZATION, AMERICAN ASSOCIATION OF BLOOD BANKS. AMERICAN ASSOCIATION OF BLOOD BANKS 8101 GLENDBROOK ROAD BETHESDA MD 20814 362384118 PATIENT SAFETY IL 501(C)(3) LINE 7 N/A 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 0 0 0